Top

Published in:

01-04-2022 | Septicemia | Original Article

Unfractionated Heparin Attenuated Histone-Induced Pulmonary Syndecan-1 Degradation in Mice: a Preliminary Study on the Roles of Heparinase Pathway

Authors: Sifeng Fu, Sihan Yu, Yilin Zhao, Xiaochun Ma, Xu Li

Published in: Inflammation | Issue 2/2022

Abstract—

Endothelial glycocalyx degradation is thought to facilitate the development of sepsis. Histone is a significant mediator in sepsis. Unfractionated heparin (UFH) possessed beneficial effects on sepsis. Thereby, this study aims to figure out whether histone can disrupt glycocalyx and to investigate the protective effect and mechanism of UFH. Male mice (C57BL/6, 8–10 weeks old, weighing 20–25 g) were randomly divided into five groups including control group, histone group, histone + UFH group, histone + heparinase (HPA) inhibitor group, and histone + UFH + HPA inhibitor group. The mice were treated with histone (50 mg/kg) via tail vein immediately after HPA (20 mg/kg) injection. UFH (400 U/kg) was injected 1h after histone administration. The other groups were injected with equal volume of sterile saline accordingly. UFH alleviated histone-induced lung injury and pulmonary edema. UFH inhibited histone-induced lung coagulation activation and inflammatory response. UFH treatment markedly inhibited pulmonary glycocalyx degradation by reducing the histone-induced decrease in the levels of lung syndecan-1 mRNA and protein. UFH downregulated histone-induced expression of HPA mRNA and protein, and thus alleviated glycocalyx degradation. UFH protects against histone-induced pulmonary glycocalyx injury partly by heparinase pathway.

Singer, M., C.S. Deutschman, C.W. Seymour, M. Shankar-Hari, D. Annane, M. Bauer, R. Bellomo, et al. 2016. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315(8): 801-810. https://doi.org/10.1001/jama.2016.0287.CrossRefPubMedPubMedCentral

Prescott, H.C., and D.C. Angus. 2018. Enhancing Recovery From Sepsis: A Review. JAMA 319(1): 62-75. https://doi.org/10.1001/jama.2017.17687.CrossRefPubMedPubMedCentral

Allam, R., S.V.R. Kumar, M.N. Darisipudi, and H. Anders. 2014. Extracellular histones in tissue injury and inflammation. Journal of Molecular Medicine 92(5): 465-472. https://doi.org/10.1007/s00109-014-1148-z.CrossRefPubMed

Xu, J., X.M. Zhang, M. Monestier, N.L. Esmon, and C.T. Esmon. 2011. Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury. Journal of Immunology 187(5): 2626–2631. https://doi.org/10.4049/jimmunol.1003930.CrossRef

Ammollo, C.T., F. Semeraro, J. Xu, N.L. Esmon, and C.T. Esmon. 2011. Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation. Journal of Thrombosis and Haemostasis 9(9): 1795–1803. https://doi.org/10.1111/j.1538-7836.2011.04422.x.CrossRefPubMed

Xu, J., X. Zhang, R. Pelayo, M. Monestier, C.T. Ammollo, F. Semeraro, F.B. Taylor, N.L. Esmon, F. Lupu, and C.T. Esmon. 2009. Extracellular histones are major mediators of death in sepsis. Nature Medicine 15(11): 1318–1321. https://doi.org/10.1038/nm.2053.CrossRefPubMedPubMedCentral

Abrams, S.T., N. Zhang, J. Manson, T.T. Liu, C. Dart, F. Baluwa, S.S. Wang, et al. 2013. Circulating histones are mediators of trauma-associated lung injury. American journal of respiratory and critical care medicine. 187(2): 160–169. https://doi.org/10.1164/rccm.201206-1037OC.CrossRefPubMedPubMedCentral

Reitsma, S., D.W. Slaaf, H. Vink, M.A.M.J. van Zandvoort, and G.A.M oude Egbrink. 2007. The endothelial glycocalyx: Composition functions and visualization. Pflugers Archiv: European journal of physiology 454(3): 345–359. https://doi.org/10.1007/s00424-007-0212-8. CrossRef

Wang, W. 2007. Change in properties of the glycocalyx affects the shear rate and stress distribution on endothelial cells. Journal of Biomechanical Engineering 129(3): 324–329. https://doi.org/10.1115/1.2720909. CrossRef

10.

Becker, B.F., M. Jacob, S. Leipert, A.H.J. Salmon, and D. Chappell. 2015. Degradation of the endothelial glycocalyx in clinical settings: Searching for the sheddases. British Journal of Clinical Pharmacology 80(3): 389–402. https://doi.org/10.1111/bcp.12629.CrossRefPubMedPubMedCentral

11.

Salmon, A.H.J., and S.C. Satchell. 2012. Endothelial glycocalyx dysfunction in disease: Albuminuria and increased microvascular permeability. The Journal of Pathology 226(4): 562–574. https://doi.org/10.1002/path.3964.CrossRefPubMed

12.

Yang, Y., V. Macleod, H.Q. Miao, A. Theus, F.H. Zhan, J.D. Shaughnessy, J. Sawyer, et al. 2007. Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis. The Journal of biological chemistry 282(18): 13326-13333. https://doi.org/10.1074/jbc.M611259200.

13.

Schmidt, E.P., Y. Yang, W.J. Janssen, A. Gandjeva, M.J. Perez, L. Barthel, R.L. Zemans, et al. 2012. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nature medicine 18(8): 1217–1223. https://doi.org/10.1038/nm.2843.CrossRefPubMed

14.

Sallisalmi, M., J. Tenhunen, R. Yang, N. Oksala, and V. Pettilä. 2012. Vascular adhesion protein-1 and syndecan-1 in septic shock. Acta anaesthesiologica Scandinavica 56(3): 316-322. https://doi.org/10.1111/j.1399-6576.2011.02578.x.CrossRefPubMed

15.

Piotti, A., D. Novelli, J.M.T. Anna Meessen, D. Ferlicca, S. Coppolecchia, A. Marino, and G. Salati, et al. 2021. Endothelial damage in septic shock patients as evidenced by circulating syndecan-1 sphingosine-1-phosphate and soluble VE-cadherin: a substudy of ALBIOS. Critical care (London, England) 25(1): 113. https://doi.org/10.1186/s13054-021-03545-1.

16.

Zhang, X.J., and X. Li. 2021. The Role of Histones and Heparin in Sepsis: A Review. Journal of intensive care medicine 885066621992320. https://doi.org/10.1177/0885066621992320.CrossRefPubMed

17.

Sun, Y.N., H. Zhang, X. An, and X.C. Ma. 2015. Effect of unfractionated heparin on endothelial glycocalyx in a septic shock model. Acta Anaesthesiologica Scandinavica 59(2): 160–169. https://doi.org/10.1111/aas.12418.CrossRef

18.

Li, X., and X. Ma. 2017. The role of heparin in sepsis: Much more than just an anticoagulant. British Journal of Haematology 179(3): 389–398. https://doi.org/10.1111/bjh.14885.CrossRefPubMed

19.

Li, L., S.H. Yu, S.F. Fu, X.C. Ma, and X. Li. 2020. Unfractionated heparin inhibits histone-mediated coagulation activation and thrombosis in mice. Thrombosis research 193: 122-129. https://doi.org/10.1016/j.thromres.2020.06.007.CrossRefPubMed

20.

Shimada, K., S. Anai, T. Fujii, N. Tanaka, K. Fujimoto, and N. Konishi. 2013. Syndecan-1 (CD138) contributes to prostate cancer progression by stabilizing tumour-initiating cells. The Journal of pathology 231(4): 495-504. https://doi.org/10.1002/path.4271.CrossRefPubMed

21.

Ding, R.Y., D.M. Zhao, R.X. Guo, Z.D. Zhang, and X.C. Ma. 2011. Treatment with unfractionated heparin attenuates coagulation and inflammation in endotoxemic mice. Thrombosis Research 128(6): e160–e165. https://doi.org/10.1016/j.thromres.2011.07.044.CrossRefPubMed

22.

Alhamdi, Y., M. Zi, S.T. Abrams, T. Liu, Su. Dunhao, I. Welters, T. Dutt, E.J. Cartwright, G. Wang, and C.H. Toh. 2016. Circulating Histone Concentrations Differentially Affect the Predominance of Left or Right Ventricular Dysfunction in Critical Illness. Critical care medicine 44(5): e278-e288. https://doi.org/10.1097/CCM.0000000000001413.CrossRef

23.

Song, W.Y., X.H. Jiang, Y. Ding, Y. Wang, M.X. Zhou, Y. Xia, C.Y. Zhang CY, et al. 2020. Inhibition of heparanase protects against pancreatic beta cell death in streptozotocin-induced diabetic mice via reducing intra-islet inflammatory cell infiltration. British Journal of Pharmacology 177(19): 4433-4447. https://doi.org/10.1111/bph.15183. CrossRefPubMedPubMedCentral

24.

Chappell, D., M. Jacob, O. Paul, M. Rehm, U. Welsch, M. Stoeckelhuber, P. Conzen, and B.F. Becker. 2009. The glycocalyx of the human umbilical vein endothelial cell: An impressive structure ex vivo but not in culture. Circulation research 104(11): 1313-1317. Circulation research. https://doi.org/10.1161/CIRCRESAHA.108.187831.CrossRefPubMed

25.

Matute-Bello, G., G. Downey, B.B. Moore, S.D. Groshong, M.A. Matthay, A.S. Slutsky, and W.M. Kuebler. 2011. An official American Thoracic Society workshop report: Features and measurements of experimental acute lung injury in animals. American journal of respiratory cell and molecular biology 44(5): 725-738. https://doi.org/10.1165/rcmb.2009-0210ST.CrossRefPubMedPubMedCentral

26.

Yu, Y., A.N. Böing, C.M. Hau, N.Hajji, W. Ruf, A. Sturk, and R. Nieuwland. 2018. Tissue Factor Coagulant Activity is Regulated by the Plasma Membrane Microenvironment. Thrombosis and haemostasis 118(6): 990-1000. https://doi.org/10.1055/s-0038-1642031.CrossRefPubMedPubMedCentral

27.

Hakimi, S., S.S. Caroline, C. Hesse, and A. Jeppsson. 2019. Effects of fibrinogen and platelet transfusion on coagulation and platelet function in bleeding cardiac surgery patients. Acta anaesthesiologica Scandinavica 63(4): 475-482. https://doi.org/10.1111/aas.13295.CrossRef

28.

Xiong, S., Z. Hong, L.S. Huang, Y. Tsukasaki, S. Nepal, A. Di, M. Zhong, et al. 2020. IL-1β suppression of VE-cadherin transcription underlies sepsis-induced inflammatory lung injury. The Journal of clinical investigation 130(7): 3684-3698. https://doi.org/10.1172/JCI136908.CrossRefPubMedPubMedCentral

29.

Kim, H.B., S. Soh, Y.L. Kwak, J.C. Bae, S.H. Kang, and J.W. Song. 2020. High Preoperative Serum Syndecan-1 a Marker of Endothelial Glycocalyx Degradation, and Severe Acute Kidney Injury after Valvular Heart Surgery. Journal of clinical medicine 9(6): 1803. https://doi.org/10.3390/jcm9061803.CrossRefPubMedPubMedCentral

30.

Xu, Z.H., Y.B. Huang, P. Mao, J.R. Zhang, and Y.M. Li. 2015. Sepsis and ARDS: The Dark Side of Histones. Mediators of inflammation 2015:205054. https://doi.org/10.1155/2015/205054.CrossRefPubMedPubMedCentral

31.

Grailer, J.J., B.A. Canning, M. Kalbitz, M.D. Haggadone, R. M. Dhond, A.V. Andjelkovic, F.S. Zetoune, and P.A. Ward. 2014. Critical role for the NLRP3 inflammasome during acute lung injury. Journal of immunology 192(12): 5974-5983. https://doi.org/10.4049/jimmunol.1400368.CrossRef

32.

Fuchs, T.A., A.A. Bhandari, and D.D. Wagner. 2011. Histones induce rapid and profound thrombocytopenia in mice. Blood 118(13): 3708-3714. https://doi.org/10.1182/blood-2011-01-332676.CrossRefPubMedPubMedCentral

33.

Vassiliou, A.G., A. Kotanidou, I. Dimopoulou, and S.E. Orfanos. 2020. Endothelial Damage in Acute Respiratory Distress Syndrome. International Journal of Molecular Sciences 21(22): 8793. https://doi.org/10.3390/ijms21228793.CrossRefPubMedPubMedCentral

34.

Joffre, J., J. Hellman, C. Ince, and H. Ait-Oufella. 2020. Endothelial Responses in Sepsis. American journal of respiratory and critical care medicine 202(3): 361-370. https://doi.org/10.1164/rccm.201910-1911TR.CrossRefPubMed

35.

Pries, A.R., and W.M. Kuebler. 2006. Normal endothelium. Handbook of experimental pharmacology (176 Pt 1):1-40. https://doi.org/10.1007/3-540-32967-6_1.

36.

Keyloun, J.W., T.D. Le, A.E. Pusateri, R.L. Ball, B.C. Carney, T. Orfeo, K.E. Brummel-Ziedins, et al. 2020. Circulating Syndecan-1 and Tissue Factor Pathway Inhibitor Biomarkers of Endothelial Dysfunction Predict Mortality in Burn Patients. Shock 56(2): 237-244. https://doi.org/10.1097/SHK.0000000000001709.CrossRefPubMedPubMedCentral

37.

Holzmann, M.S., M.S. Winkler, M.S. Strunden, J.R. Izbicki, G. Schoen, . Greiwe, H.O. Pinnschmidt, et al. 2018. Syndecan-1 as a biomarker for sepsis survival after major abdominal surgery. Biomarkers in medicine 12(2): 119-127. https://doi.org/10.2217/bmm-2017-0231.CrossRefPubMed

38.

Van den Berg, B.M., M. Nieuwdorp, E.S.G. Stroes, and H. Vink. 2006. Glycocalyx and endothelial (dys) function: from mice to men. Pharmacological Report 58 Suppl:75-80.

39.

Lipowsky, H.H. 2012. The endothelial glycocalyx as a barrier to leukocyte adhesion and its mediation by extracellular proteases. Annals of biomedical engineering 40(4): 840-848. https://doi.org/10.1007/s10439-011-0427-x.CrossRefPubMed

40.

Fux, L., N. Ilan, R.D. Sanderson, and I. Vlodavsky. 2009. Heparanase: Busy at the cell surface. Trends in biochemical sciences 34(10): 511-519. https://doi.org/10.1016/j.tibs.2009.06.005.CrossRefPubMedPubMedCentral

41.

Purushothaman, A., L. Chen, Y. Yang, and R.D. Sanderson. 2008. Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma. The Journal of biological chemistry 283(47): 32628-32636. https://doi.org/10.1074/jbc.M806266200.CrossRefPubMedPubMedCentral

42.

Mayfosh, A.J., N. Baschuk, and M.D. Hulett. 2019. Leukocyte Heparanase: A Double-Edged Sword in Tumor Progression. Frontiers in oncology 9: 331. https://doi.org/10.3389/fonc.2019.00331.CrossRefPubMedPubMedCentral

43.

Szatmári, T., R. Ötvös, A. Hjerpe, and K. Dobra. 2015. Syndecan-1 in Cancer: Implications for Cell Signaling Differentiation and Prognostication. Disease markers 2015:796052. https://doi.org/10.1155/2015/796052.CrossRefPubMedPubMedCentral

44.

Goldberg, R., A. Meirovitz, N. Hirshoren, R.Bulvik, A. Binder, A.M. Rubinstein, and M. Elkin. 2013. Versatile role of heparanase in inflammation. Matrix biology: Journal of the International Society for Matrix Biology 32(5): 234-240. https://doi.org/10.1016/j.matbio.2013.02.008.

45.

Massena, S., G. Christoffersson, E. Hjertström, E. Zcharia, I. Vlodavsky, N. Ausmees, C. Rolny, J.P. Li, and M. Phillipson. 2010. A chemotactic gradient sequestered on endothelial heparan sulfate induces directional intraluminal crawling of neutrophils. Blood 116(11): 1924-1931. https://doi.org/10.1182/blood-2010-01-266072.CrossRefPubMedPubMedCentral

46.

Zhao, C., Z.D. Zhang, X.J. Zhang, X. Li, R. Zhu, and X.C. Ma. 2009. Evaluation of clinical effects on low-dose heparin therapy for sepsis. Zhonghua nei ke za zhi [Chinese journal of internal medicine] 48: 566–569.

47.

Spiess, B.D. 2017. Heparin: Effects upon the Glycocalyx and Endothelial Cells. The Journal of extra-corporeal Technology 49(3): 192-197.

48.

Wildhagen, K.C., P. García de Frutos, C.P. Reutelingsperger, R. Schrijver, C. Aresté, A. Ortega-Gómez, N.M. Deckers, H. Coenraad Hemker, O. Soehnlein, and G.A. Nicolaes. 2014. Nonanticoagulant heparin prevents histone-mediated cytotoxicity in vitro and improves survival in sepsis. Blood 123(7): 1098-1101. https://doi.org/10.1182/blood-2013-07-514984.CrossRefPubMed

49.

Freeman, C.G., C.R. Parish, K.J. Knox, J.L. Blackmore, S.A. Lobov, D.W. King, T.J. Senden, and R.W. Stephens. 2013. The accumulation of circulating histones on heparan sulphate in the capillary glycocalyx of the lungs. Biomaterials 34(22): 5670-5676. https://doi.org/10.1016/j.biomaterials.2013.03.091.CrossRefPubMed

50.

Li, X., X. Li, Z. Zheng, Y.N. Liu, and X.C. Ma. 2014. Unfractionated heparin suppresses lipopolysaccharide-induced monocyte chemoattractant protein-1 expression in human microvascular endothelial cells by blocking Krüppel-like factor 5 and nuclear factor-κB pathway. Immunobiology 219(1): 778–785. https://doi.org/10.1016/j.imbio.2014.06.005.CrossRefPubMed

51.

Zhao, D.M., R.Y. Ding, Y.N. Liu, X.H. Yin, Z.D. Zhang, and X.C. Ma. 2017. Unfractionated heparin protects the protein C system against lipopolysaccharide-induced damage in vivo and in in vitro. Experimental and therapeutic medicine 14(6): 5515-5522. https://doi.org/10.3892/etm.2017.5236.CrossRefPubMedPubMedCentral

52.

Iba, T., N. Hashiguchi, I. Nagaoka, Y. Tabe, K. Kadota, and K. Sato. 2015. Heparins attenuated histone-mediated cytotoxicity in vitro and improved the survival in a rat model of histone-induced organ dysfunction. Intensive care medicine experimental 3(1): 36. https://doi.org/10.1186/s40635-015-0072-z.CrossRefPubMedPubMedCentral

Title: Unfractionated Heparin Attenuated Histone-Induced Pulmonary Syndecan-1 Degradation in Mice: a Preliminary Study on the Roles of Heparinase Pathway
Authors: Sifeng Fu
Sihan Yu
Yilin Zhao
Xiaochun Ma
Xu Li
Publication date: 01-04-2022
Publisher: Springer US
Keywords: Septicemia
Septicemia
Heparin
Published in: Inflammation / Issue 2/2022
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI: https://doi.org/10.1007/s10753-021-01578-w

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Unfractionated Heparin Attenuated Histone-Induced Pulmonary Syndecan-1 Degradation in Mice: a Preliminary Study on the Roles of Heparinase Pathway

Abstract—

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract—

Please log in to get access to this content

Other articles of this Issue 2/2022

Syringaresinol Resisted Sepsis-Induced Acute Lung Injury by Suppressing Pyroptosis Via the Oestrogen Receptor-β Signalling Pathway

Resveratrol Alleviates Hepatic Fibrosis in Associated with Decreased Endoplasmic Reticulum Stress-Mediated Apoptosis and Inflammation

Performance of High Mobility Protein Group 1 and Interleukin-6 as Predictors of Outcomes Resulting from Variceal Bleeding in Patients with Advanced Chronic Liver Disease

Neutrophil Extracellular Trap Formation Potential Correlates with Lung Disease Severity in COVID-19 Patients

Dynamic Changes of NCR− Type 3 Innate Lymphoid Cells and Their Role in Mice with Bronchopulmonary Dysplasia

Intestinal Protein Characterisation of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in Inflammatory Bowel Disease (IBD) and Fatal COVID-19 Infection

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page